Bridging The Drug Price Divide: Ideas And Approaches Debated At PSA
Executive Summary
Leaders from across the industry met at Informa's Pharmaceutical Strategy conference and addressed some of the most critical issues facing the industry: pharma's tarnished reputation and drug pricing.
You may also be interested in...
US Drug Spending: Where Does All The Money Go?
PhRMA has released new data on where gross and net drug expenditure ends up along the pharmaceutical supply chain, which will support its position the debate over US drug pricing.
Drug Pricing ‘Biggest Offenders’ Are Annual Increases On Widely Used Brands
Express Scripts Chief Medical Officer Steve Miller suggests that caps on annual price increases could significantly ease payer concerns over drug pricing.
Pharma CEOs Tackle A Tough Question: “Why Don’t People Like You?”
Pfizer CEO Ian Read, Regeneron CEO Leonard Schleifer, Gilead CEO John Milligan and Lilly’s incoming CEO David Ricks discussed pharma’s reputation problem during the Forbes Healthcare Summit.